CX3CR1 and type 2 diabetes mellitus: Furthermore, we observed a distinct increase in expression of CX3CR1 in CD4+ EM and EMRA populations (Fig. 2e,g) and the CD8+ naive, EM and EMRA T cell populations of people living with T2D (Fig. 2f,h).